Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 23, 2023

Dapagliflozin in Patients With Myocardial Infarction Without Diabetes or Heart Failure

NEJM Evidence


Additional Info

NEJM Evidence
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
NEJM Evid 2023 Nov 11;[EPub Ahead of Print], S James, D Erlinge, RF Storey, et al

Further Reading